Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why These Stocks Are in Spotlight Today

Danaher Expands
Two months after spinning off some of its test & measurement/industrial assets, Danaher Corporation (NYSE:DHR) is buying Cepheid (NASDAQ:CPHD) for $53 per share in cash, which represents an enterprise value of around $4 billion. Cepheid’s board has already unanimously approved the transaction, which should close in the fourth quarter. Cepheid management said the following about the reason for the sale:

“Looking forward as a part of Danaher and its $5 billion Diagnostics platform, we believe that Cepheid will be able to reach an extended level of customers and patients more quickly than we could have on a standalone basis. Our employees will have more opportunities as part of a global science and technology company that shares Cepheid’s commitment to innovation, and also has the capability to help accelerate expansion of our global market position.”

Predictably, Cepheid shares are up by 52% in morning trading while Danaher’s shares are relatively flat. Our data shows that smart money investors were more bullish on both companies in the second quarter. A total of 54 funds tracked by us owned shares of Danaher Corporation (NYSE:DHR) at the end of June, up by eight over the quarter, while 17 investors were long Cepheid (NASDAQ:CPHD), compared to 13 funds at the end of March

Follow Danaher Corp (NYSE:DHR)
Trade (NYSE:DHR) Now!

Follow Cepheid (NASDAQ:CPHD)
Trade (NASDAQ:CPHD) Now!

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.